Holly Lebowitz Rossi
February 28, 2012

The Wall Street Journal is reporting on a new niche for lenders--fertility treatments including in vitro fertilization.   So-called "fertility finance" companies are increasingly reaching out to women who are facing the expensive and often long road of medical fertility interventions, offering loans to cover the costs and enable women to start treatment before saving up all the money they will need.  Critics say the companies are taking advantage, offering unreasonably high interest rates--as high as 22 percent.

Image: Couple signing papers, via Shutterstock.

Advertisement


Comments

Be the first to comment!